Hagop M. Kantarjian, MD¹, Michael W. Deininger, MD, PhD², Elisabetta Abruzzese, MD ³, Jane Apperley, FRCP, FRCPath, MB ⁴, Jorge E. Cortes, MD⁵, Charles Chuah, MD⁶, Daniel J. DeAngelo, MD, PhD⁷, John F. DiPersio, MD⁸, Andreas Hochhaus, MD⁹, Jeffrey H. Lipton, MD, PhD¹⁰, Franck E Nicolini, MD, PhD¹¹, Javier Pinilla Ibarz, MD, PhD¹², Delphine Rea, MD, PhD^13,14, Gianantonio Rosti, MD^15*, Philippe Rousselot, MD PhD^16*, Neil P Shah, MD, PhD^17*, Moshe Talpaz, MD¹⁸, Shouryadeep Srivastava, MBBS, PhD^19*, Vickie Lu, PhD^20* and Michael J. Mauro, MD²¹

¹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
³S. Eugenio Hospital, Tor Vergata University, Rome, Italy
⁴Centre for Haematology, Imperial College London, London, United Kingdom
⁵Georgia Cancer Center Augusta University, Augusta, GA
⁶Singapore General Hospital, Duke-NUS Medical School, Singapore, Singapore
⁷Department of Medical Oncology, Dana-Farber Cancer Inst., Boston, MA
⁸Washington University School of Medicine, Saint Louis, MO
⁹Jena University Hospital, Jena, Germany
¹⁰Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
¹¹Hématologie Clinique, Centre Léon Bérard, Lyon, France
¹²H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
¹³Hôpital Saint Louis, Paris, France
¹⁴Hôpital Saint-Louis, Paris, France
¹⁵University of Bologna, Bologna, Italy
¹⁶Hospital Mignot University de Versailles Saint-Quentin-en-Yvelines, Paris, France
¹⁷University of California San Francisco, San Francisco, CA
¹⁸Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
¹⁹Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
²⁰Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
²¹Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Monica Bocchia^1*, Anna Sicuranza, PhD^2*, Paola Pacelli^2,3*, Alessandra Iurlo, MD, PhD^4*, Elisabetta Abruzzese, MD ⁵, Sara Galimberti, MD, PhD^6*, Patrizia Pregno^7*, Giovanni Caocci, MD^8,9, Isabella Capodanno, MD^10*, Monica Crugnola, MD^11*, Antonella Gozzini, MD^12*, Claudio Fozza, MD^13*, Mario Annunziata, MD^14*, Sabina Russo^15*, Anna Marina Liberati^16*, Olga Mulas^17*, Daniele Cattaneo^18*, Adele Santoni^19*, Vincenzo Sammartano^19*, Federico Caroni^20* and Donatella Raspadori^2*

¹Hematology, University of Siena, Siena, Italy
²Hematology, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy
³Department of Medical Biotechnologies, University of Siena, Siena, Italy
⁴Hematology Division, Foundation IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy
⁵Department of Hematology S. Eugenio Hospital, Rome, Italy, Roma, Italy
⁶Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy
⁷AZ OSP CITTA' DELLA SALUTE E SCIENZA TORINO, University of Torino, TORINO, Italy
⁸Ematologia-Centro Trapianti Midollo Osseo, Ospedale Businco, Dipartimento di Scienze mediche e Sanità Pubblica, Università di Cagliari, Cagliari, Italy
⁹Hematology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, ITA
¹⁰Hematology Unit, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy
¹¹Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
¹²Hematology Unit, AOU Careggi, University of Florence, Florence, ITA
¹³Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy
¹⁴Hematology Unit, Cardarelli Hospital, Naples, Italy
¹⁵Dipartimento di Medicina Interna, AOU Policlinico di Messina, Messina, Italy
¹⁶S.C. Oncoematologia, Università degli Studi di Perugia, A.O. Santa Maria, Terni, Italy
¹⁷Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
¹⁸FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO, MILANO, ITA
¹⁹Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, ITA
²⁰Hematology Unit, University of Siena and Azienda Ospedaliera Universitaria Senese, Siena, Italy

Delphine Rea, MD, PhD¹, Michael J. Mauro, MD², Jorge E. Cortes, MD³, Qian Jiang, MD⁴, Katia B Pagnano, MD, PhD⁵, Matilda Ongondi, MD^6*, Chung Hoow Kok, BSc, PhD^7*, Nicola Evans^8*, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA⁹ and International CML Foundation^10*

¹Université de Paris, Hematology department, Saint-Louis hospital, APHP, Paris, France
²Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Georgia Cancer Center Augusta University, Augusta, GA
⁴Peking University People’s Hospital, Beijing, China
⁵University of Campinas, Campinas, Brazil
⁶Kenyatta National Hospital, Nairobi, KEN
⁷Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
⁸International CML Foundation, Adelaide, SA, Australia
⁹South Australian Health and Medical Research Institute SAHMRI, Adelaide, SA, Australia
¹⁰iCMLf, Bexhill-On-Sea, United Kingdom

Jorge E. Cortes, MD¹, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA², Michael J. Mauro, MD³, Andreas Hochhaus, MD⁴, Delphine Rea, MD, PhD⁵, Yeow Tee Goh, MBBS⁶, Jeroen Janssen^7*, Juan Luis Steegmann⁸, Michael C. Heinrich, MD^9*, Moshe Talpaz, MD¹⁰, Gabriel Etienne, MD, PhD^11*, Massimo Breccia, MD^12*, Michael W. Deininger, MD, PhD¹³, Philipp D le Coutre, MD¹⁴, Fabian Lang, MD^15*, Paola Aimone, MD^16*, Fotis Polydoros^16*, Silvia Cacciatore^16*, Laura Stenson^17* and Dong-Wook Kim, MD¹⁸

¹Georgia Cancer Center Augusta University, Augusta, GA
²South Australian Health and Medical Research Institute SAHMRI, Adelaide, SA, Australia
³Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Klinik für Innere Medizin II, Jena, Germany
⁵Hopital Saint Louis, Paris, France
⁶Department of Hematology, Singapore General Hospital, Singapore, Singapore
⁷VU University Medical Center, Amsterdam, NLD
⁸Hospital de La Princesa, Madrid, Spain
⁹Portland VA Health Care System, Portland, OR
¹⁰University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
¹¹Hematology Department, Institut Bergonié, Bordeaux, France
¹²Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
¹³Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT
¹⁴Charité – Universitätsmedizin Berlin, Berlin, Berlin, Germany
¹⁵Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany
¹⁶Novartis Pharma AG, Basel, Switzerland
¹⁷Novartis Ireland Limited, Dublin, Ireland
¹⁸Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, Korea, Republic of (South)

Qian Jiang, MD¹, Xiaojun Huang, MD¹, Zi Chen, MD^2*, Qian Niu, MD^2*, Dayu Shi^1*, Zongru Li^1*, Yue Hou^1*, Yu Hu, MD^3*, Weiming Li, PhD^3*, Xiaoli Liu^4*, Na Xu^4*, Yongping Song, MD^5*, Yanli Zhang^5*, Li Meng, MD, PhD^6*, Zhenya Hong, MD, PhD^6*, Bingcheng Liu^7*, Shan Zeng^2*, Lichuang Men^2*, Yan Li, MD^8*, Suning Chen^9*, Mengxing Xue, PhD^10*, Huanling Zhu, MD^11*, He Li^11*, Xin Du^12*, Jin Lou, MD^12*, Xiaohan Zhang^12*, Yang Liang, MD¹³, Yujun Dai, MD, PhD^13*, Ming Lu, PhD^14*, Hengbang Wang^2*, Jiao JI, PhD, MD^2*, Changai Yue^2*, Dajun Yang, MD, PhD^15,16* and Yifan Zhai, MD, PhD^2,14*

¹Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
²Guangzhou Healthquest Pharma Co. Ltd., Guangzhou, China
³Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁴Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
⁵Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
⁶Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁷Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
⁸Institute of Hematology and Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Tianjin, China
⁹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
¹⁰Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
¹¹Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
¹²Division of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
¹³Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
¹⁴Ascentage Pharma Group Inc., Rockville, MD
¹⁵Ascentage Pharma (SuZhou) Co., Ltd, Suzhou, China
¹⁶Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China

Jorge E. Cortes, MD¹, Tapan Saikia, MD², Dong-Wook Kim, MD^3,4, Yesid Alvarado, MD⁵, Franck E Nicolini, MD, PhD⁶, Navin Khattry, MD, DM^7*, Krishnakumar Rathnam, MD, DM^8*, Jane Apperley, FRCP, FRCPath, MB ⁹, Michael W. Deininger, MD, PhD¹⁰, Hugues de Lavallade, MD, PhD^11*, Aude Charbonnier, MD, PhD^12*, Nikki Granacher, MD^13*, Carlo Gambacorti-Passerini, MD¹⁴, Alessandro Lucchesi, MD^15*, Michael J. Mauro, MD¹⁶, Gregor Verhoef, MD, PhD^17*, Peter Vandenberghe, MD¹⁸, Andrew R. Whiteley, MD¹⁹, Shashikant Apte, MD, FRCPA²⁰, Siu-Long Yao, MD²¹, Mudgal Kothekar, MD^22*, Jayasree Sreenivasan, MSc^22*, Bimba HV, MD^22* and Geetanjali Chimote, MD, PhD^22*

¹Georgia Cancer Center Augusta University, Augusta, GA
²Prince Aly Khan Hospital, Mumbai, India
³Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁴Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁵Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁶Hematology department & ISERM U590, Centre Hospitalier Lyon Sud, LYON Cedex 03, France
⁷BMT unit, Department of Medical oncology, ACTREC., Tata Memorial Centre, Navi Mumbai, India
⁸Lake Area,Melur Main Rd, Meenakshi Mission Hospital and Research Centre, Tamil Nadu, India
⁹Centre for Haematology, Department of Medicine, Hammersmith Hospital, Imperial College, London, United Kingdom
¹⁰Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹¹Department of Haematological Medicine, Kings College Hospital, NHS Foundation Trust, London, United Kingdom
¹²Onco-Hematology Department, Paoli-Calmette Cancer Institute, Marseille, France
¹³Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
¹⁴Dept of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy
¹⁵Hematology Unit,, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), FC, Italy
¹⁶Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁷Department of Hematology, University Hospitals Leuven, Leuven, Belgium
¹⁸Center for Human Genetics, University of Leuven Center for Human Genetics, Leuven, Belgium
¹⁹Baylor University Medical Center, Dallas, TX
²⁰Department of Haematology, Sahyadri Specialty Hospitals, Pune, India
²¹Sun Pharmaceutical Industries, Inc., Princeton, NJ
²²Clinical Research Department, Sun Pharma Advanced Research Company, Mumbai, Maharashtra, India